DIANE HEARN: Open Payments
NPI 1023370921 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 32 payments from 20 companies in 2025. Trend: 2023 $1,817 · 2024 $1,516 · 2025 $991
Food & beverage: $806Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $191 |
| ABBVIE INC. | 5 | $137 |
| Lilly USA, LLC | 2 | $124 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| Pharmacosmos Therapeutics Inc. | 2 | $60 |
| Iovance Biotherapeutics, Inc. | 1 | $39 |
| Alexion Pharmaceuticals, Inc. | 1 | $33 |
| Caris MPI, Inc. | 1 | $30 |
| Tempus AI, Inc | 1 | $29 |
| BeOne Medicines USA, Inc. | 1 | $29 |
Products named: DARZALEX, MONOFERRIC, RYBREVANT, Amtagvi, IMBRUVICA, ULTOMIRIS, SCEMBLIX, EPKINLY.
Industry payments across MD — which companies pay providers there.
